Insulet Total Non-Cash Items 2010-2025 | PODD

Insulet annual/quarterly total non-cash items history and growth rate from 2010 to 2025. Total non-cash items can be defined as the total of all non-cash charges adjusting Net Income on the Cash Flows Statement
  • Insulet total non-cash items for the quarter ending March 31, 2025 were $0.093B, a 157.3% increase year-over-year.
  • Insulet total non-cash items for the twelve months ending March 31, 2025 were $44M, a 86.63% decline year-over-year.
  • Insulet annual total non-cash items for 2024 were $0.029B, a 77.69% decline from 2023.
  • Insulet annual total non-cash items for 2023 were $0.13B, a 11.21% increase from 2022.
  • Insulet annual total non-cash items for 2022 were $0.117B, a 34.58% decline from 2021.
Insulet Annual Total Non-Cash Items
(Millions of US $)
2024 $29
2023 $130
2022 $117
2021 $179
2020 $141
2019 $107
2018 $85
2017 $66
2016 $58
2015 $53
2014 $71
2013 $42
2012 $35
2011 $18
2010 $33
2009 $21
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.046B $2.072B
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.226B 28.28
Boston Scientific (BSX) United States $157.620B 39.46
Stryker (SYK) United States $148.687B 31.09
EssilorLuxottica (ESLOY) France $134.580B 0.00
Medtronic (MDT) Ireland $110.773B 16.17
Lonza Group Ag (LZAGY) Switzerland $50.060B 0.00
Haleon (HLN) United Kingdom $49.664B 28.26
ResMed (RMD) United States $36.384B 27.33
GE HealthCare Technologies (GEHC) United States $32.899B 15.62
Agilent Technologies (A) United States $32.353B 21.37
Terumo (TRUMY) Japan $27.583B 35.83
Koninklijke Philips (PHG) Netherlands $22.521B 16.19
Zimmer Biomet Holdings (ZBH) United States $18.865B 12.12
Baxter (BAX) United States $16.144B 12.05
Smith & Nephew SNATS (SNN) United Kingdom $12.881B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.231B 0.00
Bio-Rad Laboratories (BIO) United States $6.723B 23.40
Lantheus Holdings (LNTH) United States $5.316B 13.41
Prestige Consumer Healthcare (PBH) United States $4.327B 19.33
Perrigo (PRGO) Ireland $3.770B 9.55
Haemonetics (HAE) United States $3.462B 15.08
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.321B 24.49
Envista Holdings (NVST) United States $3.012B 25.03
QuidelOrtho (QDEL) United States $2.190B 15.06
GN Store Nord (GNNDY) Denmark $2.097B 17.37
LeMaitre Vascular (LMAT) United States $1.915B 42.80
AtriCure (ATRC) United States $1.686B 0.00
Neogen (NEOG) United States $1.346B 17.22
Kestra Medical Technologies (KMTS) United States $1.280B 0.00
AdaptHealth (AHCO) United States $1.248B 12.67
Green Thumb Industries (GTBIF) United States $1.207B 27.14
BioLife Solutions (BLFS) United States $1.083B 0.00
Phibro Animal Health (PAHC) United States $0.976B 12.48
InMode (INMD) Israel $0.933B 9.40
CeriBell (CBLL) United States $0.657B 0.00
Evolus (EOLS) United States $0.642B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.611B 0.00
Curaleaf Holdings (CURLF) Canada $0.580B 0.00
Owens & Minor (OMI) United States $0.564B 4.68
Valneva SE (VALN) France $0.536B 0.00
Capricor Therapeutics (CAPR) United States $0.503B 0.00
Tilray Brands (TLRY) Canada $0.456B 0.00
Surmodics (SRDX) United States $0.424B 0.00
Cresco Labs (CRLBF) United States $0.358B 0.00
SNDL (SNDL) Canada $0.349B 0.00
VAREX IMAGING (VREX) United States $0.335B 12.33
Canopy Growth (CGC) Canada $0.325B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.300B 0.00
Aurora Cannabis (ACB) Canada $0.300B 53.40
Sanara MedTech (SMTI) United States $0.276B 0.00
Viemed Healthcare (VMD) United States $0.269B 22.67
Verano Holdings (VRNOF) United States $0.262B 0.00
Sanuwave Health (SNWV) United States $0.257B 0.00
Cerus (CERS) United States $0.256B 0.00
ZimVie (ZIMV) United States $0.247B 11.24
Biote (BTMD) United States $0.218B 6.12
OraSure Technologies (OSUR) United States $0.209B 0.00
Brainsway (BWAY) Israel $0.202B 53.45
Quanterix (QTRX) United States $0.194B 0.00
Omeros (OMER) United States $0.193B 0.00
High Tide (HITI) Canada $0.190B 0.00
Organigram Global (OGI) Canada $0.181B 0.00
Utah Medical Products (UTMD) United States $0.176B 14.34
TriSalus Life Sciences (TLSI) United States $0.173B 0.00
FitLife Brands (FTLF) United States $0.131B 16.18
Exagen (XGN) United States $0.127B 0.00
Jin Medical (ZJYL) China $0.124B 0.00
TerrAscend (TSNDF) Canada $0.123B 0.00
Agape ATP (ATPC) $0.108B 0.00
MacroGenics (MGNX) United States $0.099B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Fonar (FONR) United States $0.088B 11.30
Veru (VERU) United States $0.075B 0.00
Zynex (ZYXI) United States $0.075B 0.00
InterCure (INCR) Israel $0.073B 0.00
Jushi Holdings (JUSHF) United States $0.066B 0.00
Apyx Medical (APYX) United States $0.056B 0.00
United Health Products (UEEC) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.050B 0.00
United-Guardian (UG) United States $0.040B 13.87
Rockwell Medical (RMTI) United States $0.037B 0.00
Modular Medical (MODD) United States $0.036B 0.00
Safety Shot (SHOT) United States $0.029B 0.00
Nephros (NEPH) United States $0.024B 32.93
Allurion Technologies (ALUR) United States $0.024B 0.00
INLIF (INLF) $0.019B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Acuren (TIC) United States $0.000B 0.00